Loriox India Pharmaceuticals Private Limited
About Loriox India Pharmaceuticals Private Limited
Data last updated:
Loriox India Pharmaceuticals Private Limited is a private limited company based in Hyderabad, Telangana, India. It operates in the diversified business activities segment of the business services sector. It was incorporated on 14 March 2018 and has been in existence for over 8 years.
The company is registered with the Registrar of Companies (ROC), Hyderabad, under CIN U74999TG2018PTC122983. Its GSTIN is 36AADCL5511F1ZT (Telangana).
The company has an authorised share capital of ₹10 Lakh and a paid-up capital of ₹50,000. It is led by directors including Jajula Poojitha and Mamatha Gandham.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at Plot No 258/P Road No 5 Bhagya Lakshmi Colony Subashnagar Quthbullapur Jeedimetla, Hyderabad, Telangana, India – 500055.
As per the financials filed for FY 2024, the company reported a revenue of ₹93,884. For the same year it recorded a net profit of ₹492 (net margin 0.5%) and EBITDA of ₹31,504 (EBITDA margin 33.6%). Revenue has declined at a compounded annual rate (CAGR) of 26% over five years.
The current compliance status is marked as compliant by the Registrar of Companies.
Company details
Contact details
Loriox India Pharmaceuticals Private Limited's registered office is in Hyderabad, Telangana.
- Registered AddressPlot No 258/P Road No 5 Bhagya Lakshmi Colony Subashnagar Quthbullapur Jeedimetla, Hyderabad, Telangana, India – 500055
- IndustryBusiness Services, Miscellaneous Business Activities, Other Services
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Business activity
The main business activity of Loriox India Pharmaceuticals is trade. In detail, this covers wholesale trading.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| G | Trade | G1 | Wholesale Trading |
To see the full business activity and turnover split of Loriox India Pharmaceuticals Private Limited, buy the company report.
Financials of Loriox India Pharmaceuticals Private Limited
FY 2025 filings availableLoriox India Pharmaceuticals Private Limited reported revenue of ₹93,884 for FY 2024.
Compounded Annual Growth Rate (CAGR)
Revenue has declined at a compounded annual rate (CAGR) of 26% over five years. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | ₹31,504 | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | ₹492 | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 33.6% | ||||
| Net Profit Margin | 0.5% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Loriox India Pharmaceuticals Private Limited, buy the company report.
Board of directors of Loriox India Pharmaceuticals Private Limited
Loriox India Pharmaceuticals has 3 current directors and 2 former directors. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Jajula Poojitha | Director | 16 Jan 2025 | 1 Years 9 Months | Current |
| Mamatha Gandham | Director | 16 Jan 2025 | 1 Years 9 Months | Current |
| Srujana Kothakapu | Director | 16 Jan 2025 | 1 Years 9 Months | Current |
Legal cases
No court or tribunal cases involving Loriox India Pharmaceuticals Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Loriox India Pharmaceuticals Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
Loriox India Pharmaceuticals has 1 GST registration: 1 active.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 36AADCL5511F1ZT | Telangana | Active | 03 May 2018 |
To see the full GST registrations and return filing status of Loriox India Pharmaceuticals Private Limited, buy the company report.
Recent activity
Loriox India Pharmaceuticals Private Limited has 5 board changes on record since 2025: 3 appointments and 2 cessations. The latest: Suresh Gandham ceased to be Director on 15 Feb 2025.
Frequently asked questions
Loriox India Pharmaceuticals is an active private limited company based in Hyderabad, Telangana, India. The company works in miscellaneous business activities, within the business services industry. It was incorporated on 14 March 2018 (8+ years old) and is registered under CIN U74999TG2018PTC122983.
Loriox India Pharmaceuticals has 3 current directors:
- Jajula Poojitha - Director
- Mamatha Gandham - Director
- Srujana Kothakapu - Director
The latest financial statements of Loriox India Pharmaceuticals on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from FY 2018 are in the company report.
The GSTIN of Loriox India Pharmaceuticals is 36AADCL5511F1ZT, registered in Telangana.
The CIN (Corporate Identification Number) of Loriox India Pharmaceuticals is U74999TG2018PTC122983. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Loriox India Pharmaceuticals was incorporated on 14 March 2018, making it 8+ years old. It is registered with the Registrar of Companies, Hyderabad.
Suresh Gandham ceased to be Director on 15 Feb 2025. Jajula Poojitha was appointed as Director on 16 Jan 2025. Mamatha Gandham was appointed as Director on 16 Jan 2025. Loriox India Pharmaceuticals has 5 board changes on record in total.
The registered office of Loriox India Pharmaceuticals is at Plot No 258P Road No 5 Bhagya Lakshmi Colony Subashnagar Quthbullapur Jeedimetla, Hyderabad, Telangana, India – 500055.
Loriox India Pharmaceuticals operates in the business services industry, in the miscellaneous business activities segment.
The compliance status of Loriox India Pharmaceuticals is compliant as of 24 July 2026. The company is actively filing with the Registrar of Companies.
Sample company reports
The same report you get when you buy one: financials, directors, ownership, deals, charges, legal cases, brands and filings, with the Excel workbook alongside.
